[1]
Becker AB, Abrams EM. Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines. Current opinion in allergy and clinical immunology. 2017 Apr:17(2):99-103. doi: 10.1097/ACI.0000000000000346. Epub
[PubMed PMID: 28118238]
Level 3 (low-level) evidence
[2]
Martin J, Townshend J, Brodlie M. Diagnosis and management of asthma in children. BMJ paediatrics open. 2022 Apr:6(1):. doi: 10.1136/bmjpo-2021-001277. Epub
[PubMed PMID: 35648804]
[3]
Di Cicco M, Peroni DG, Ragazzo V, Comberiati P. Application of exhaled nitric oxide (FeNO) in pediatric asthma. Current opinion in allergy and clinical immunology. 2021 Apr 1:21(2):151-158. doi: 10.1097/ACI.0000000000000726. Epub
[PubMed PMID: 33620882]
Level 3 (low-level) evidence
[4]
Gruber KJ, McKee-Huger B, Richard A, Byerly B, Raczkowski JL, Wall TC. Removing asthma triggers and improving children's health: The Asthma Partnership Demonstration project. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2016 May:116(5):408-14. doi: 10.1016/j.anai.2016.03.025. Epub
[PubMed PMID: 27153740]
[5]
Maciag MC, Phipatanakul W. Preventing the development of asthma: stopping the allergic march. Current opinion in allergy and clinical immunology. 2019 Apr:19(2):161-168. doi: 10.1097/ACI.0000000000000501. Epub
[PubMed PMID: 30507718]
Level 3 (low-level) evidence
[6]
Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, Dixon AE, Elward KS, Hartert T, Krishnan JA, Lemanske RF Jr, Ouellette DR, Pace WD, Schatz M, Skolnik NS, Stout JW, Teach SJ, Umscheid CA, Walsh CG. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. The Journal of allergy and clinical immunology. 2020 Dec:146(6):1217-1270. doi: 10.1016/j.jaci.2020.10.003. Epub
[PubMed PMID: 33280709]
[7]
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes. American journal of respiratory and critical care medicine. 2022 Jan 1:205(1):17-35. doi: 10.1164/rccm.202109-2205PP. Epub
[PubMed PMID: 34658302]
[8]
Silva D, Jacinto T. Inhaled β(2)-agonists in asthma management: an evolving story. Breathe (Sheffield, England). 2016 Dec:12(4):375-377. doi: 10.1183/20734735.017116. Epub
[PubMed PMID: 28210324]
[9]
Cates CJ, Wieland LS, Oleszczuk M, Kew KM. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews. The Cochrane database of systematic reviews. 2014 Feb 6:2014(2):CD010314. doi: 10.1002/14651858.CD010314.pub2. Epub 2014 Feb 6
[PubMed PMID: 24504983]
Level 1 (high-level) evidence
[10]
Ridha Z, Bédard MA, Smyrnova A, Drouin O, Pruteanu A, Essouri S, Ducharme FM. Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 2021 Dec 12:17(1):129. doi: 10.1186/s13223-021-00632-4. Epub 2021 Dec 12
[PubMed PMID: 34895321]
[11]
Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. British journal of clinical pharmacology. 2015 Sep:80(3):372-80. doi: 10.1111/bcp.12637. Epub 2015 May 28
[PubMed PMID: 25808113]
[12]
Hossny E, Rosario N, Lee BW, Singh M, El-Ghoneimy D, Soh JY, Le Souef P. The use of inhaled corticosteroids in pediatric asthma: update. The World Allergy Organization journal. 2016:9():26. doi: 10.1186/s40413-016-0117-0. Epub 2016 Aug 12
[PubMed PMID: 27551328]
[13]
Hoefgen ER, Huang B, Schuler CL, Kercsmar CM, Murtagh-Kurowski E, Forton M, Auger KA. Dexamethasone Versus Prednisone in Children Hospitalized With Asthma Exacerbation. Hospital pediatrics. 2022 Mar 1:12(3):325-335. doi: 10.1542/hpeds.2021-006276. Epub
[PubMed PMID: 35128557]
[14]
Rowe BH, Edmonds ML, Spooner CH, Diner B, Camargo CA Jr. Corticosteroid therapy for acute asthma. Respiratory medicine. 2004 Apr:98(4):275-84
[PubMed PMID: 15072167]
[15]
Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis. Expert opinion on pharmacotherapy. 2004 Mar:5(3):679-86
[PubMed PMID: 15013935]
Level 3 (low-level) evidence
[16]
Lee YJ, Kim CK. Montelukast use over the past 20 years: monitoring of its effects and safety issues. Clinical and experimental pediatrics. 2020 Oct:63(10):376-381. doi: 10.3345/cep.2019.00325. Epub 2020 Feb 5
[PubMed PMID: 32023405]
[17]
Rossi A, Pergola C, Koeberle A, Hoffmann M, Dehm F, Bramanti P, Cuzzocrea S, Werz O, Sautebin L. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. British journal of pharmacology. 2010 Oct:161(3):555-70. doi: 10.1111/j.1476-5381.2010.00930.x. Epub
[PubMed PMID: 20880396]
[18]
Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. British journal of pharmacology. 2013 Sep:170(1):23-37. doi: 10.1111/bph.12138. Epub
[PubMed PMID: 23441583]
[19]
Brogden RN, Speight TM, Avery GS. Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs. 1974:7(3):164-282
[PubMed PMID: 4212341]
[20]
Barnes PJ. Theophylline. American journal of respiratory and critical care medicine. 2013 Oct 15:188(8):901-6. doi: 10.1164/rccm.201302-0388PP. Epub
[PubMed PMID: 23672674]
[21]
Chipps BE, Lanier B, Milgrom H, Deschildre A, Hedlin G, Szefler SJ, Kattan M, Kianifard F, Ortiz B, Haselkorn T, Iqbal A, Rosén K, Trzaskoma B, Busse WW. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience. The Journal of allergy and clinical immunology. 2017 May:139(5):1431-1444. doi: 10.1016/j.jaci.2017.03.002. Epub
[PubMed PMID: 28477722]
[22]
Pavord ID, Menzies-Gow A, Buhl R, Chanez P, Dransfield M, Lugogo N, Keene ON, Bradford ES, Yancey SW. Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine. The journal of allergy and clinical immunology. In practice. 2021 Mar:9(3):1121-1132.e7. doi: 10.1016/j.jaip.2020.08.039. Epub 2020 Sep 2
[PubMed PMID: 32889223]
[23]
Canonica GW, Harrison TW, Chanez P, Menzella F, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, Garcia Gil E. Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis. Allergy. 2022 Jan:77(1):150-161. doi: 10.1111/all.14902. Epub 2021 Jun 8
[PubMed PMID: 33978983]
[24]
Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. The New England journal of medicine. 2018 Jun 28:378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21
[PubMed PMID: 29782217]
[25]
Parashar S, Pandya A, Portnoy JM. Pediatric subcutaneous allergen immunotherapy. Allergy and asthma proceedings. 2022 Jul 1:43(4):286-291. doi: 10.2500/aap.2022.43.210114. Epub
[PubMed PMID: 35818145]
[26]
Cloutier MM, Teach SJ, Lemanske RF Jr, Blake KV. The 2020 Focused Updates to the NIH Asthma Management Guidelines: Key Points for Pediatricians. Pediatrics. 2021 Jun:147(6):. doi: 10.1542/peds.2021-050286. Epub 2021 May 3
[PubMed PMID: 33941586]
[27]
Pade KH, Agnihotri NT, Vangala S, Thompson LR, Wang VJ, Okelo SO. Asthma specialist care preferences among parents of children receiving emergency department care for asthma. The Journal of asthma : official journal of the Association for the Care of Asthma. 2020 Feb:57(2):188-195. doi: 10.1080/02770903.2019.1565768. Epub 2019 Jan 21
[PubMed PMID: 30663904]
[28]
Misra SM. The Current Evidence of Integrative Approaches to Pediatric Asthma. Current problems in pediatric and adolescent health care. 2016 Jun:46(6):190-4. doi: 10.1016/j.cppeds.2015.12.009. Epub 2016 Jan 28
[PubMed PMID: 26832885]
[29]
Axelsson I, Naumburg E, Prietsch SO, Zhang L. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. The Cochrane database of systematic reviews. 2019 Jun 10:6(6):CD010126. doi: 10.1002/14651858.CD010126.pub2. Epub 2019 Jun 10
[PubMed PMID: 31194879]
Level 1 (high-level) evidence
[30]
Clarridge K, Chin S, Eworuke E, Seymour S. A Boxed Warning for Montelukast: The FDA Perspective. The journal of allergy and clinical immunology. In practice. 2021 Jul:9(7):2638-2641. doi: 10.1016/j.jaip.2021.02.057. Epub 2021 Mar 17
[PubMed PMID: 33744471]
Level 3 (low-level) evidence
[31]
Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CA, Bonini M, Cavkaytar O, Flood B, Gajdanowicz P, Izuhara K, Kalayci Ö, Mosges R, Palomares O, Pfaar O, Smolinska S, Sokolowska M, Asaria M, Netuveli G, Zaman H, Akhlaq A, Sheikh A. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017 Dec:72(12):1825-1848. doi: 10.1111/all.13208. Epub 2017 Jul 6
[PubMed PMID: 28543086]
Level 1 (high-level) evidence
[32]
Casale TB, Chipps BE, Rosén K, Trzaskoma B, Haselkorn T, Omachi TA, Greenberg S, Hanania NA. Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. Allergy. 2018 Feb:73(2):490-497. doi: 10.1111/all.13302. Epub 2017 Sep 23
[PubMed PMID: 28859263]
[33]
Hardin AP, Hackell JM, COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE. Age Limit of Pediatrics. Pediatrics. 2017 Sep:140(3):. pii: e20172151. doi: 10.1542/peds.2017-2151. Epub 2017 Aug 21
[PubMed PMID: 28827380]
[34]
Kew KM, Dahri K. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. The Cochrane database of systematic reviews. 2016 Jan 21:2016(1):CD011721. doi: 10.1002/14651858.CD011721.pub2. Epub 2016 Jan 21
[PubMed PMID: 26798035]
Level 1 (high-level) evidence
[35]
Lovinsky-Desir S. The use of biologic therapies for the management of pediatric asthma. Pediatric pulmonology. 2020 Mar:55(3):803-808. doi: 10.1002/ppul.24613. Epub 2019 Dec 27
[PubMed PMID: 31880870]
[36]
Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR, American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. American journal of respiratory and critical care medicine. 2011 Sep 1:184(5):602-15. doi: 10.1164/rccm.9120-11ST. Epub
[PubMed PMID: 21885636]
Level 1 (high-level) evidence
[37]
Cazzola M, Page CP, Rogliani P, Matera MG. β2-agonist therapy in lung disease. American journal of respiratory and critical care medicine. 2013 Apr 1:187(7):690-6. doi: 10.1164/rccm.201209-1739PP. Epub
[PubMed PMID: 23348973]
[38]
Leung JS, Johnson DW, Sperou AJ, Crotts J, Saude E, Hartling L, Stang A. A systematic review of adverse drug events associated with administration of common asthma medications in children. PloS one. 2017:12(8):e0182738. doi: 10.1371/journal.pone.0182738. Epub 2017 Aug 9
[PubMed PMID: 28793336]
Level 1 (high-level) evidence
[39]
Dusser D, Ducharme FM. Safety of tiotropium in patients with asthma. Therapeutic advances in respiratory disease. 2019 Jan-Dec:13():1753466618824010. doi: 10.1177/1753466618824010. Epub
[PubMed PMID: 30795731]
Level 3 (low-level) evidence
[40]
Aljebab F, Choonara I, Conroy S. Systematic review of the toxicity of short-course oral corticosteroids in children. Archives of disease in childhood. 2016 Apr:101(4):365-70. doi: 10.1136/archdischild-2015-309522. Epub 2016 Jan 14
[PubMed PMID: 26768830]
Level 1 (high-level) evidence
[41]
Comstock TL, Decory HH. Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate. International journal of inflammation. 2012:2012():789623. doi: 10.1155/2012/789623. Epub 2012 Mar 28
[PubMed PMID: 22536546]
Level 3 (low-level) evidence
[42]
Buchman AL. Side effects of corticosteroid therapy. Journal of clinical gastroenterology. 2001 Oct:33(4):289-94
[PubMed PMID: 11588541]
[43]
Butler E, Møller MH, Cook O, Granholm A, Penketh J, Rygård SL, Aneman A, Perner A. The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis. Intensive care medicine. 2019 Nov:45(11):1540-1549. doi: 10.1007/s00134-019-05754-3. Epub 2019 Sep 9
[PubMed PMID: 31501997]
Level 1 (high-level) evidence
[45]
Glacy J, Putnam K, Godfrey S, Falzon L, Mauger B, Samson D, Aronson N. Treatments for Seasonal Allergic Rhinitis. 2013 Jul:():
[PubMed PMID: 23946962]
[46]
Holgate ST. Clinical evaluation of nedocromil sodium in asthma. European journal of respiratory diseases. Supplement. 1986:147():149-59
[PubMed PMID: 3021489]
[47]
Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, Rajagopalan B, American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association. Circulation. 2020 Oct 13:142(15):e214-e233. doi: 10.1161/CIR.0000000000000905. Epub 2020 Sep 15
[PubMed PMID: 32929996]
[48]
Balbino B, Herviou P, Godon O, Stackowicz J, Goff OR, Iannascoli B, Sterlin D, Brûlé S, Millot GA, Harris FM, Voronina VA, Nadeau KC, Macdonald LE, Murphy AJ, Bruhns P, Reber LL. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors. The Journal of clinical investigation. 2020 Mar 2:130(3):1330-1335. doi: 10.1172/JCI129697. Epub
[PubMed PMID: 31770111]
[49]
Fildan AP, Rajnoveanu RM, Cirjaliu R, Pohrib I, Tudorache E, Ilie AC, Oancea C, Tofolean D. Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review). Experimental and therapeutic medicine. 2021 Nov:22(5):1263. doi: 10.3892/etm.2021.10698. Epub 2021 Sep 6
[PubMed PMID: 34603531]
[50]
Gillette C, Rockich-Winston N, Kuhn JA, Flesher S, Shepherd M. Inhaler Technique in Children With Asthma: A Systematic Review. Academic pediatrics. 2016 Sep-Oct:16(7):605-15. doi: 10.1016/j.acap.2016.04.006. Epub 2016 Apr 26
[PubMed PMID: 27130811]
Level 1 (high-level) evidence
[51]
Pearce CJ, Fleming L. Adherence to medication in children and adolescents with asthma: methods for monitoring and intervention. Expert review of clinical immunology. 2018 Dec:14(12):1055-1063. doi: 10.1080/1744666X.2018.1532290. Epub 2018 Oct 15
[PubMed PMID: 30286679]
[52]
Kaplan A, Szefler SJ, Halpin DMG. Impact of comorbid conditions on asthmatic adults and children. NPJ primary care respiratory medicine. 2020 Aug 20:30(1):36. doi: 10.1038/s41533-020-00194-9. Epub 2020 Aug 20
[PubMed PMID: 32820164]
[53]
Chupp G, Kline JN, Khatri SB, McEvoy C, Silvestri GA, Shifren A, Castro M, Bansal S, McClelland M, Dransfield M, Trevor J, Kahlstrom N, Simoff M, Wahidi MM, Lamb CR, Ferguson JS, Haas A, Hogarth DK, Tejedor R, Toth J, Hey J, Majid A, LaCamera P, Fitzgerald JM, Enfield K, Grubb GM, McMullen EA, Olson JL, Laviolette M. Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study. Chest. 2022 Mar:161(3):614-628. doi: 10.1016/j.chest.2021.10.044. Epub 2021 Nov 10
[PubMed PMID: 34774528]
[54]
Thornton E, Kennedy S, Hayes-Watson C, Krouse RZ, Mitchell H, Cohn RD, Wildfire J, Mvula MM, Lichtveld M, Grimsley F, Martin WJ 2nd, Stephens KU. Adapting and implementing an evidence-based asthma counseling intervention for resource-poor populations. The Journal of asthma : official journal of the Association for the Care of Asthma. 2016 Oct:53(8):825-34. doi: 10.3109/02770903.2016.1155219. Epub 2016 Apr 6
[PubMed PMID: 27049234]
[55]
Olufemi-Yusuf DT, Gabriel SB, Makhinova T, Guirguis LM. "Being in Control of My Asthma Myself" Patient Experience of Asthma Management: A Qualitative Interpretive Description. Pharmacy (Basel, Switzerland). 2018 Nov 15:6(4):. doi: 10.3390/pharmacy6040121. Epub 2018 Nov 15
[PubMed PMID: 30445719]
[56]
Quirt J, Hildebrand KJ, Mazza J, Noya F, Kim H. Asthma. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 2018:14(Suppl 2):50. doi: 10.1186/s13223-018-0279-0. Epub 2018 Sep 12
[PubMed PMID: 30275843]
[57]
Reeves PT, Kenny TM, Mulreany LT, McCown MY, Jacknewitz-Woolard JE, Rogers PL, Echelmeyer S, Welsh SK. Development and assessment of a low literacy, pictographic asthma action plan with clinical automation to enhance guideline-concordant care for children with asthma. The Journal of asthma : official journal of the Association for the Care of Asthma. 2023 Apr:60(4):655-672. doi: 10.1080/02770903.2022.2087188. Epub 2022 Jun 16
[PubMed PMID: 35658804]
[58]
Battula M, Arunashekar P, Nagarajan VP. A Prospective Study to Assess the Quality of Life in Children with Newly Diagnosed Asthma and Their Caregivers using the Pediatric Asthma Quality of Life Questionnaire. Journal of primary care & community health. 2020 Jan-Dec:11():2150132720961272. doi: 10.1177/2150132720961272. Epub
[PubMed PMID: 33016181]
Level 2 (mid-level) evidence
[59]
Mazurek JM, Syamlal G. Prevalence of Asthma, Asthma Attacks, and Emergency Department Visits for Asthma Among Working Adults - National Health Interview Survey, 2011-2016. MMWR. Morbidity and mortality weekly report. 2018 Apr 6:67(13):377-386. doi: 10.15585/mmwr.mm6713a1. Epub 2018 Apr 6
[PubMed PMID: 29621204]
Level 3 (low-level) evidence
[60]
Zablotsky B, Black LI. Concordance between survey reported childhood asthma and linked Medicaid administrative records. The Journal of asthma : official journal of the Association for the Care of Asthma. 2019 Mar:56(3):285-295. doi: 10.1080/02770903.2018.1455854. Epub 2018 May 17
[PubMed PMID: 29771597]
Level 3 (low-level) evidence
[61]
Caridi MN, Humann MJ, Liang X, Su FC, Stefaniak AB, LeBouf RF, Stanton ML, Virji MA, Henneberger PK. Occupation and task as risk factors for asthma-related outcomes among healthcare workers in New York City. International journal of hygiene and environmental health. 2019 Mar:222(2):211-220. doi: 10.1016/j.ijheh.2018.10.001. Epub 2018 Oct 13
[PubMed PMID: 30327176]
[62]
Kanannejad Z, Alyasin S, Esmaeilzadeh H, Nabavizadeh H, Amin R. Asthma and COVID-19 pandemic: focus on the eosinophil count and ACE2 expression. European annals of allergy and clinical immunology. 2022 Nov:54(6):284-289. doi: 10.23822/EurAnnACI.1764-1489.233. Epub 2021 Sep 10
[PubMed PMID: 34503323]
[63]
Ioniuc I, Miron I, Lupu VV, Starcea IM, Azoicai A, Alexoae M, Adam Raileanu A, Dragan F, Lupu A. Challenges in the Pharmacotherapeutic Management of Pediatric Asthma. Pharmaceuticals (Basel, Switzerland). 2022 Dec 18:15(12):. doi: 10.3390/ph15121581. Epub 2022 Dec 18
[PubMed PMID: 36559032]
[64]
Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma Surveillance - United States, 2006-2018. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002). 2021 Sep 17:70(5):1-32. doi: 10.15585/mmwr.ss7005a1. Epub 2021 Sep 17
[PubMed PMID: 34529643]
Level 2 (mid-level) evidence
[65]
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. The European respiratory journal. 2020 Apr:55(4):. doi: 10.1183/13993003.01872-2019. Epub 2020 Apr 16
[PubMed PMID: 31949111]
[66]
Fonseca W, Monteiro C, Taborda-Barata L. Inhaled Drug Therapy-Associated Adverse Reactions in Obstructive Respiratory Diseases: A Review of a Decade of Reporting to the Portuguese Pharmacovigilance System. International journal of environmental research and public health. 2021 Nov 25:18(23):. doi: 10.3390/ijerph182312411. Epub 2021 Nov 25
[PubMed PMID: 34886135]
[67]
Wahab F, Rahman RA, Yaacob LH, Noor NM, Draman N. A Case Report of Steroid Withdrawal Syndrome. Korean journal of family medicine. 2020 Sep:41(5):359-362. doi: 10.4082/kjfm.18.0181. Epub 2020 Sep 18
[PubMed PMID: 32961047]
Level 3 (low-level) evidence
[68]
Kong A, Ghosh S, Guan C, Fries BL, Burke FW. Acute on Chronic Theophylline Toxicity in an Elderly Patient. Cureus. 2021 Feb 22:13(2):e13484. doi: 10.7759/cureus.13484. Epub 2021 Feb 22
[PubMed PMID: 33777571]
[69]
Tanaka S, Tsuji T, Shiotsu S, Yuba T, Hiraoka N. Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis. Cureus. 2022 May:14(5):e25218. doi: 10.7759/cureus.25218. Epub 2022 May 22
[PubMed PMID: 35747049]
[70]
Tesse R, Borrelli G, Mongelli G, Mastrorilli V, Cardinale F. Treating Pediatric Asthma According Guidelines. Frontiers in pediatrics. 2018:6():234. doi: 10.3389/fped.2018.00234. Epub 2018 Aug 23
[PubMed PMID: 30191146]
[71]
Wooler E. The role of the nurse in paediatric asthma management. Paediatric respiratory reviews. 2001 Mar:2(1):76-81
[PubMed PMID: 16263484]
[72]
Zhang W, Wang Q, Liu L, Yang W, Liu H. Effects of physical therapy on lung function in children with asthma: a systematic review and meta-analysis. Pediatric research. 2021 May:89(6):1343-1351. doi: 10.1038/s41390-020-0874-x. Epub 2020 Apr 3
[PubMed PMID: 32244247]
Level 1 (high-level) evidence
[73]
Miller AG, Haynes KE, Gates RM, Zimmerman KO, Heath TS, Bartlett KW, McLean HS, Rehder KJ. A Respiratory Therapist-Driven Asthma Pathway Reduced Hospital Length of Stay in the Pediatric Intensive Care Unit. Respiratory care. 2019 Nov:64(11):1325-1332. doi: 10.4187/respcare.06626. Epub 2019 May 14
[PubMed PMID: 31088987]
[74]
Nikolaizik W, Wuensch L, Bauck M, Gross V, Sohrabi K, Weissflog A, Hildebrandt O, Koehler U, Weber S. Pilot study on nocturnal monitoring of crackles in children with pneumonia. ERJ open research. 2021 Oct:7(4):. pii: 00284-2021. doi: 10.1183/23120541.00284-2021. Epub 2021 Nov 29
[PubMed PMID: 34853781]
Level 3 (low-level) evidence
[75]
Leung D, Ensom MHH, Carr R. Survey of Therapeutic Drug Monitoring Practices in Pediatric Health Care Programs across Canada. The Canadian journal of hospital pharmacy. 2019 Mar-Apr:72(2):126-132
[PubMed PMID: 31036973]
Level 3 (low-level) evidence
[76]
Guo H, Zhao Q, Li SY, Xu X, Xu N, Lv C, Shen ZS, Li JG. Successful treatment of fatal asthma combined with a silent chest: A case report. The Journal of international medical research. 2020 May:48(5):300060520925683. doi: 10.1177/0300060520925683. Epub
[PubMed PMID: 32466702]
Level 3 (low-level) evidence